Literature DB >> 26612792

Daylight PDT with MAL - current data and practical recommendations of an expert panel.

Wolfgang G Philipp-Dormston1, Sigrid Karrer2, Holger Petering3, Claas Ulrich4, Thomas Dirschka5, Carola Berking6, Anke S Lonsdorf7, Peter Arne Gerber8, Sonja Radakovic9, Robert E Hunger10, Rolf-Markus Szeimies11.   

Abstract

Photodynamic Therapy (PDT) is one of the standard treatment modalities for actinic keratoses (AKs). Daylight PDT (DL-PDT) with MAL cream is a rather recent development, which, instead of an artificial light source, uses daylight for the activation of the photosensitizer. The present review summarizes available data based on a selective literature search, highlights practical aspects, and reflects the authors' expert knowledge in using DL-PDT. With respect to efficacy, study data shows that DL-PDT is noninferior to conventional PDT (cPDT). However, given that DL-PDT is markedly less painful, it is significantly better tolerated than cPDT. In Europe, DL-PDT can be performed from March to October, on sunny as well as on cloudy days. UV protection of untreated areas of the body should be observed. Outside temperature should not fall below 10°C. On hot days, patients should be advised to stay in the shade if necessary. Representing a useful addition to current therapeutic options, DL-PDT with MAL cream is, among others, suitable for patients with field cancerization and/or those who have experienced severe pain associated with cPDT.
© 2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26612792     DOI: 10.1111/ddg.12807

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  5 in total

Review 1.  [Photodynamic therapy-trends and new developments].

Authors:  R-M Szeimies; S Karrer
Journal:  Hautarzt       Date:  2020-12-10       Impact factor: 0.751

2.  [Daylight photodynamic therapy : Back to the future?]

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

3.  Weather-informed Light-tissue Model-Based Dose Planning for Indoor Daylight Photodynamic Therapy.

Authors:  Ethan P M LaRochelle; Michael Shane Chapman; Edward V Maytin; Tayyaba Hasan; Brian W Pogue
Journal:  Photochem Photobiol       Date:  2019-10-21       Impact factor: 3.421

4.  [Decision criteria and patient characteristics for patient-oriented treatment of field cancerization : Standardized algorithm for personalized treatment concepts].

Authors:  W G Philipp-Dormston; R Aschoff; T von Braunmühl; T Eigentler; T Haalck; K-M Thoms
Journal:  Hautarzt       Date:  2021-04       Impact factor: 0.751

Review 5.  Daylight-PDT: everything under the sun.

Authors:  Dana Beiki; Ian M Eggleston; Charareh Pourzand
Journal:  Biochem Soc Trans       Date:  2022-04-29       Impact factor: 4.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.